Navigation Links
A G8 report released today in Paris indicating an increase in financing for women's and children's health
Date:5/19/2011

A G8 report released today in Paris indicating an increase in financing for women's and children's health was welcomed by the Partnership for Maternal, Newborn and Child Health (PMNCH).

In 2010, the G8 launched the Muskoka Initiative for Maternal, Newborn and Child Health, with an initial commitment of US$5 billion by 2015. The G8 2011 Accountability Report today suggests that collectively the G8 will surpass this initial commitment by roughly 53%.

"The G8 continues to lead on maternal, newborn and child health," says Dr. Julio Frenk, Chair of the Board of PMNCH, and Dean of Harvard's School of Public Health.

"Under Canada in 2010, Muskoka was a game changer in terms of donor commitments. In 2011, France has focussed on accountability, which is critically important to ensuring that commitments are honoured," he says.

"The US G8 year in 2012 will also be an important opportunity for progress, given the strong US record on accountability, as well as their strong support for women in development," said Dr. Carole Presern, PMNCH Director.

The 2011 G8 report outlines commitments to the Muskoka Initiative by each G8 member: Canada - C$1.1 billion; France - 500 million; Germany - 400 million; Italy - US$75 million; Japan - US$500 million; Russia - US$75 million; United Kingdom - 2.1 billion; US - US$1.346 billion; EU - $70 million.

While the G8 does not provide a new aggregate figure, a roll-up of each commitment suggests that collectively G8 members will spend US$7.656 billion for the Muskoka Initiative by 2015. *

The increased from US$5 billion to US$7.656 billion can largely be attributed to an increased commitment by the UK in September 2010, as part of the Global Strategy for Women's and Children's Health.

The Muskoka Initiative was part of the Global Strategy, launched in September 2010 with US$40 billion in commitments, to dramatically reduce maternal, newborn and child deaths in dev
'/>"/>

Contact: Tracey Fyfe
fyfet@who.int
41-792-517-368
Partnership for Maternal, Newborn & Child Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
2. Synaptics to Report First Quarter Results on October 23
3. GEN reports on novel tools for deciphering biological networks
4. Waste from gut bacteria helps host control weight, UT Southwestern researchers report
5. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
6. Synaptics Reports Record Results for First Quarter of Fiscal 2009
7. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
8. Orchid Cellmark Reports Third Quarter 2008 Financial Results
9. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
10. Marked improvement in body image, physical stamina, post-surgical pectus patients report
11. GEN reports growing focus on PI3-kinase pathway in cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... of "tumor stem cells" maintains that a rare, stem cell-like ... cells found in a tumor and that these tumor stem ... revolutionary study appearing in the June 1 print issue of ... the Sidney Kimmel Cancer Center evaluated 1122 cancer patients diagnosed ...
... findings with implications for pandemic influenza, a new study reports ... influenza virus can spread from poultry to humans. The ... of Infectious Diseases, now available online. , Crossing the species ... flu virus with pandemic potential. Previous studies have focused on ...
... in southwest China suffer from potentially-crippling fluoride poisoning because ... researchers. , The findings, from a study carried out ... disease was caused by people burning fluoride-rich coal in ... last year, the Chinese authorities invested 34 million yuan ...
Cached Biology News:Eating, body weight regulated by specific neurons 2Fluoride poisoning in China due to clay, not coal 2
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biomarkers - Technologies, ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:9/2/2015)... 2015  Neurotech Pharmaceuticals, Inc., announced today the ... Phase 2 clinical trial of NT-503 Encapsulated Cell ... subfoveal choroidal neovascularization secondary to age related macular ... endothelial growth factor (VEGF) receptor protein continuously produced ... landmark proof-of-concept study will evaluate NT-503 ECT as ...
(Date:9/2/2015)... Israel , September 2, 2015 ... intent of the National Institute of Allergy and Infectious Diseases ... within the Department of Health and Human Services (HHS), to ... the United States in the 2015-16 ... flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which ...
(Date:9/2/2015)... Diego, CA (PRWEB) , ... September 02, 2015 ... ... troubleshooting faults in manufacturing equipment, to creating professional commercial video content, to analysis ... detailed views of fascinating events that go by too quickly to process with ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... AMSTERDAM, October 13 Amsterdam Molecular,Therapeutics ... gene therapy,announced today that the European Medicines Agency has ... for the treatment of,Duchenne muscular dystrophy. , ... (DMD) entitles,AMT to ten year market exclusivity in Europe ...
... HAIKOU CITY, China, Oct. 12 ... CPHI ), which develops,manufactures, and markets specialty pharmaceutical ... the Roth China Conference, to be held,October 12-14, 2009, ... participate in one-on-one meetings with conference attendees throughout,the three-day ...
... 12 Dr. Michael Merzenich , PhD ... brain plasticity expert and tech entrepreneur - was ... Washington, D.C. Also a member of the National Academy of ... scientists and doctors in the U.S. who have been selected ...
Cached Biology Technology:AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 2AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 3Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 2Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 3
... is a recombinant Moloney murine leukemia ... Transcriptase is similar to MuLV reverse ... usage. MuLV reverse transcriptase is a ... single-stranded RNA as a template in ...
... Application: Useful for the determination of digitonin ... sucrose, 0.4% EDTA Na 4 and 0.06% ... Nakao, et al., Biochem. Biophys. Res. Commun., ... liberate 1.0 mole of inorganic phosphorus from ATP ...
... Recombinant type 14 3C protease from ... addition to the Novagen brand line of ... a highly purified recombinant 6XHis-fusion protein, which ... native enzyme: LeuGluValLeuPheGln/GlyPro. The small, 22 KDa ...
... The IEC Centra CL3 series ... in typical research and clinical applications ... broad accessory package includes quick connect ... An advanced yet intuitive interface allows ...
Biology Products: